| 摘要 |
<p>Epidermal growth factor receptor (EGFR) inhibitor for the preparation of a medicament for the treatment of tumors whose cells proliferate as a result of a deregulated mitogenic signal transduction pathway and require the function of wildtype EGFR as a survival factor and as an inhibitor of differentiation.</p> |
